Trial Outcomes & Findings for Feasibility of Remote Exercise Training for Hispanics/Latinos With MS (NCT NCT05998616)
NCT ID: NCT05998616
Last Updated: 2026-08-07
Results Overview
Participant retention during the 16-week intervention period, reported as number of randomized participants who completed or did not complete the assigned program by study arm.
TERMINATED
NA
33 participants
Before, During, and After 16 weeks, pre-, intra- and post-Intervention
2026-08-07
Participant Flow
A total of 340 individuals were contacted between March 2024 and February 2025 through university outreach, community events, and advertisements. Of these, 112 were eligible (33%). Thirty-three participants consented and enrolled; however, the study was terminated early due to NIH funding withdrawal prior to reaching the planned sample size (N=50).
Three participants withdrew prior to randomization. Thirty participants were randomized (1:1) to the exercise intervention or flexibility control condition.
Participant milestones
| Measure |
Experimental (GEMS-based)
Participants completed a 16-week, remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
Participants completed a 16-week home-based stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Overall Study
STARTED
|
15
|
15
|
|
Overall Study
COMPLETED
|
14
|
12
|
|
Overall Study
NOT COMPLETED
|
1
|
3
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Feasibility of Remote Exercise Training for Hispanics/Latinos With MS
Baseline characteristics by cohort
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
Total
n=26 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
36.2 years
STANDARD_DEVIATION 7.8 • n=20 Participants
|
40.4 years
STANDARD_DEVIATION 15.2 • n=20 Participants
|
38.2 years
STANDARD_DEVIATION 11.6 • n=40 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=20 Participants
|
9 Participants
n=20 Participants
|
21 Participants
n=40 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=20 Participants
|
3 Participants
n=20 Participants
|
5 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Hispanic/Latino
|
14 Participants
n=20 Participants
|
12 Participants
n=20 Participants
|
26 Participants
n=40 Participants
|
|
Years of education
|
15.7 years
STANDARD_DEVIATION 2.2 • n=20 Participants
|
13.6 years
STANDARD_DEVIATION 1.6 • n=20 Participants
|
14.7 years
STANDARD_DEVIATION 2 • n=40 Participants
|
|
MS Type
RRMS
|
13 Participants
n=20 Participants
|
9 Participants
n=20 Participants
|
22 Participants
n=40 Participants
|
|
MS Type
Secondary Progressive MS
|
0 Participants
n=20 Participants
|
1 Participants
n=20 Participants
|
1 Participants
n=40 Participants
|
|
MS Type
Primary Progressive MS
|
1 Participants
n=20 Participants
|
2 Participants
n=20 Participants
|
3 Participants
n=40 Participants
|
|
Disease duration
|
7.4 years
STANDARD_DEVIATION 6.1 • n=20 Participants
|
10.8 years
STANDARD_DEVIATION 9.7 • n=20 Participants
|
9 years
STANDARD_DEVIATION 8 • n=40 Participants
|
|
Disease-modifying therapy use
Yes
|
10 Participants
n=20 Participants
|
11 Participants
n=20 Participants
|
21 Participants
n=40 Participants
|
|
Disease-modifying therapy use
No
|
4 Participants
n=20 Participants
|
1 Participants
n=20 Participants
|
5 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Normal
|
5 Participants
n=20 Participants
|
2 Participants
n=20 Participants
|
7 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Mild
|
2 Participants
n=20 Participants
|
2 Participants
n=20 Participants
|
4 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Moderate
|
2 Participants
n=20 Participants
|
2 Participants
n=20 Participants
|
4 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Gait
|
3 Participants
n=20 Participants
|
4 Participants
n=20 Participants
|
7 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Early Cane
|
2 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
2 Participants
n=40 Participants
|
|
Patient-Determined Disease Steps (PDDS)
Bilateral
|
0 Participants
n=20 Participants
|
2 Participants
n=20 Participants
|
2 Participants
n=40 Participants
|
|
Multiple Sclerosis Walking Scale-12 (MSWS-12)
|
29.5 points
STANDARD_DEVIATION 30.7 • n=20 Participants
|
38.4 points
STANDARD_DEVIATION 29.6 • n=20 Participants
|
33.6 points
STANDARD_DEVIATION 30 • n=40 Participants
|
PRIMARY outcome
Timeframe: Before, During, and After 16 weeks, pre-, intra- and post-InterventionPopulation: Thirty participants were randomized 1:1 to exercise intervention or active comparator control. Retention was analyzed using all randomized participants (15 per arm) over the 16-week intervention period.
Participant retention during the 16-week intervention period, reported as number of randomized participants who completed or did not complete the assigned program by study arm.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=15 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=15 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Process: Participant Recruitment and Retention
Did not complete 16-week program
|
1 Participants
|
3 Participants
|
|
Process: Participant Recruitment and Retention
Completed 16-week program
|
14 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Lower extremity function assessed by the 30-second sit-to-stand test (30STS). Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline value, age, sex, and education. Higher scores indicate better lower extremity function.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Lower Extremity Function
|
10.9 repetitions
Standard Deviation 0.9
|
11.2 repetitions
Standard Deviation 1.0
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Visual processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Participants were shown a key pairing symbols with numbers and were asked to verbally identify the number corresponding to each symbol as quickly as possible. The outcome is the total number of correct responses completed in 90 seconds. Higher values indicate better visual processing speed. Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline SDMT score, age, sex, and education. The raw score ranges from 0 to 110 points.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Visual Processing Speed
|
43.4 scores on a scale
Standard Error 3.3
|
41.9 scores on a scale
Standard Error 3.6
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Verbal learning and memory assessed by the California Verbal Learning Test II (CVLT-II). A list of 16 words was read aloud by the examiner and participants were asked to immediately recall as many of the words as possible, in any order. Five trials were given, and the same list of words were read aloud by the examiner at the beginning of each trial. The number of correct responses from each trial 1 through 5 (T1 to T5) was summed for a total score out of 80 max (range 0-80). Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline value, age, sex, and education. Higher scores indicate better verbal learning and memory.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Verbal Learning and Memory
|
44.2 scores on a scale
Standard Error 2.1
|
48.4 scores on a scale
Standard Error 2.3
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Fatigue severity assessed by the Fatigue Severity Scale (FSS). Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline value, age, sex, and education. Scores range from 1 to 7, with higher scores indicating greater fatigue severity.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Fatigue Severity
|
4.4 points
Standard Error 0.3
|
4.6 points
Standard Error 0.3
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Depression and Anxiety symptoms were assessed by the Hospital Anxiety and Depression Scale Depression subscale (HADS-Depression and HADS-Anxiety). Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline value, age, sex, and education. The HADS includes 14 items which can be subscored for depression (7 items) and anxiety (7 items) as separate measures. Statements in the scale are self-reported by participants as experienced "Most of the time", "A lot of the time", "From time to time, occasionally", or "Not at all". Scores for anxiety and depression subscales range from 0-21 and are categorized as 'normal' (0-7), 'mild' (8-10), 'moderate' (11-14), and 'severe' (15-21). Overall, scores range from 0 to 42 with higher scores indicating higher anxious and depressive symptoms.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Depression and Anxiety Symptoms
HADS Depression subscale
|
6.1 scores on a scale
Standard Error 1.0
|
5.4 scores on a scale
Standard Error 1.0
|
|
Depression and Anxiety Symptoms
HADS Anxiety subscale (HADS-Anxiety)
|
6.2 scores on a scale
Standard Error 1.0
|
6.5 scores on a scale
Standard Error 1.1
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Exercise behavior was assessed by Godin Leisure-Time Exercise Questionnaire (GLTEQ) total (TOT) and health contribution scores (HCS). GLTEQ TOT includes all 3 activity intensity categories (strenuous, moderate, and mild), and GLTEQ HCS with 2 (strenuous and moderate). Both scores are derived from the same frequency data (# of times per week for each activity type) and the same point values for each intensity level. Since mild activity contributes only 3 points per occurrence, removing it in the GLTEQ HCS calculation shifts the total upward but does not change the maximum possible value. The highest possible GLTEQ TOT score (999) is also the highest possible GLTEQ HCS score, and the lowest possible TOT (0) is the same as the lowest possible HCS score (0). For both, higher scores indicate greater exercise participation and represent a better outcome; lower scores indicate less exercise participation and represent a worse outcome.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Exercise Behavior
GLTEQ Total Score
|
27.4 scores on a scale
Standard Error 4.1
|
23.5 scores on a scale
Standard Error 4.5
|
|
Exercise Behavior
GLTEQ Health Contribution Score
|
19.3 scores on a scale
Standard Error 3.8
|
10.7 scores on a scale
Standard Error 2.1
|
SECONDARY outcome
Timeframe: Post-intervention at 16 weeksPopulation: Analyses were conducted among participants with complete post-intervention data. Twenty-six participants completed follow-up and were included in the published analyses (14 intervention; 12 control).
Health-related Quality of Life assessed by the Short Form -12 (SF-12), a shortened version of the short-form 36-item health survey, which measures overall health status. There are 2 composite scores, physical component summary (PCS) and mental component summary (MCS), reported as T-scores, that reflect overall perceived physical and mental health status, respectively. Both components are qualitatively measured and adjusted based on relative average (general average population is 50 with a standard deviation of 10). Both PCS and MCS T-scores are norm-based; the US population average is 50 with a standard deviation of 10. PCS and MCS T-scores above 50 are considered above average and scores below 50 are considered below average. Values shown are adjusted post-intervention means from ANCOVA models controlling for baseline value, age, sex, and education.
Outcome measures
| Measure |
Experimental (GEMS-based)
n=14 Participants
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=12 Participants
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Health-related Quality of Life
SF-12 MCS T-score
|
46.6 T-scores
Standard Error 2.6
|
49.4 T-scores
Standard Error 2.8
|
|
Health-related Quality of Life
SF-12 PCS T-score
|
46.9 T-scores
Standard Error 1.9
|
43.4 T-scores
Standard Error 2.1
|
Adverse Events
Experimental (GEMS-based)
Active Comparator
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Experimental (GEMS-based)
n=15 participants at risk
16-week remotely delivered home-based exercise program including aerobic walking and resistance training with behavioral coaching.
|
Active Comparator
n=15 participants at risk
16-week home-based flexibility/stretching program using the National MS Society manual with matching coaching contact.
|
|---|---|---|
|
Injury, poisoning and procedural complications
Fall in shower
|
0.00%
0/15 • From randomization through completion of the 16-week intervention period.
Adverse events and serious adverse events were monitored throughout the 16-week study period during remote study oversight. Two adverse events unrelated to study conditions were reported and resolved, with an average response time of 3 days.
|
6.7%
1/15 • From randomization through completion of the 16-week intervention period.
Adverse events and serious adverse events were monitored throughout the 16-week study period during remote study oversight. Two adverse events unrelated to study conditions were reported and resolved, with an average response time of 3 days.
|
|
Injury, poisoning and procedural complications
Motor vehicle accident
|
0.00%
0/15 • From randomization through completion of the 16-week intervention period.
Adverse events and serious adverse events were monitored throughout the 16-week study period during remote study oversight. Two adverse events unrelated to study conditions were reported and resolved, with an average response time of 3 days.
|
6.7%
1/15 • From randomization through completion of the 16-week intervention period.
Adverse events and serious adverse events were monitored throughout the 16-week study period during remote study oversight. Two adverse events unrelated to study conditions were reported and resolved, with an average response time of 3 days.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place